Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the first quarter ended March 31, 2013.
Quarter and Recent Highlights
•Announced acceptance of the OTREXUP™ New Drug Application (NDA) by the Food and Drug Administration (FDA) indicating that the application is sufficiently complete to permit a substantive review.
Help employers find you! Check out all the jobs and post your resume.
